November 25, 2025 - 02:42

BOSTON, Nov. 24, 2025 -- Aura Biosciences, Inc., a clinical-stage biotechnology firm focused on developing precision therapies for solid tumors, has announced its participation in the upcoming 8th Annual Evercore Healthcare Conference. The event is set to take place on Tuesday, December 2, 2025, at 10:50 a.m. ET.
Elisabet de los Pinos, PhD, the company's Chief Executive Officer, will engage in a fireside chat during the conference. This presentation will provide insights into Aura Biosciences' innovative approaches to treating solid tumors while prioritizing the preservation of organ function.
The participation in this prestigious conference highlights Aura Biosciences' commitment to advancing its therapeutic pipeline and fostering discussions around the future of oncology treatments. As the company continues to make strides in the biotechnology sector, this event serves as an opportunity for stakeholders to gain valuable perspectives on its ongoing projects and strategic vision.
July 18, 2026 - 17:01
Children of Holocaust survivors face higher schizophrenia risk, Israeli study findsA new study from Israel has found that the children of Holocaust survivors face a significantly elevated risk of developing schizophrenia. The research, conducted by a team of psychiatrists and...
July 17, 2026 - 23:32
UT San Antonio academic health center ranked among nation’s best for entrepreneurial readinessUT Health San Antonio, the academic health center affiliated with The University of Texas at San Antonio, has been named one of the top institutions in the country for its ability to turn...
July 17, 2026 - 00:12
NYC Health + Hospitals/Bellevue Completes $7 Million Modernization of Emergency Department CT SuiteNew York, NY - NYC Health + Hospitals/Bellevue has finished a major renovation of its emergency department CT imaging suite, a project costing $7 million. The upgrade is designed to speed up...
July 16, 2026 - 12:48
CMS signals intent to revamp how it pays for clinical software and AIThe Centers for Medicare and Medicaid Services has announced plans to overhaul how it reimburses healthcare providers for clinical software and artificial intelligence tools. The agency intends to...